Skip to main content
EDSA
NASDAQ Life Sciences

Edesa Biotech Prices $25M Public Offering at $5.50 with Warrants, 17% Discount

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.517
Mkt Cap
$45.891M
52W Low
$0.72
52W High
$20.32
52W Position info
527% above low
Off High info
78% below high
Rel. Volume info
2.8× avg
Market data snapshot near publication time

EDSA has more than doubled off its 52-week low of $0.72 on elevated volume (2.8× avg).

Summary

Edesa Biotech priced a $25 million public offering at $5.50 per share with warrants, a 17% discount to market, to fund operations after a going concern warning.


Key Events · Financing and Capital Events · EDSA

  • $25M Offering Priced at 17% Discount

    Edesa priced 3,870,500 common shares plus warrants at $5.50 per share, a 17% discount to the current $4.52 market price, raising gross proceeds of $25 million.

  • Warrant Overhang Adds Dilution

    Investors receive warrants to purchase up to 4,545,500 shares at $7.50, exercisable for 18 months or 30 days after Phase 2 vitiligo data for EB06, plus 675,000 pre-funded warrants at $0.0001.

  • Net Proceeds Fund Operations

    After underwriting discounts and expenses, net proceeds are approximately $23.1 million, intended for working capital, R&D, and manufacturing expenses.

  • Going Concern Addressed

    The raise follows a Q3 10-Q warning that current resources wouldn't fund operations through fiscal 2026, making this offering critical for survival.


Analysis · EDSA · Life Sciences

Edesa Biotech priced a $25 million underwritten public offering at $5.50 per share with warrants, a 17% discount to the current market price. The deal includes 3,870,500 common shares, pre-funded warrants for 675,000 shares, and warrants to purchase up to 4,545,500 shares at $7.50. Net proceeds of approximately $23.1 million will fund operations after the company's Q3 10-Q warned that current resources won't last through fiscal 2026. The deep discount and warrant overhang reflect the company's urgent need for capital, but the raise removes near-term bankruptcy risk.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EDSA was trading at $4.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $45.9M. The 52-week trading range was $0.72 to $20.32. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EDSA - Latest Insights

EDSA
Nov 09, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.35
Real-time Price: $1.83 info
Change: -$0.520 (-22%) info
Market Cap: $24.726M info
EDSA
Nov 09, 2026, 6:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.53
Real-time Price: $1.83 info
Change: -$0.6982 (-28%) info
Market Cap: $24.726M info
EDSA
Oct 23, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.77
Real-time Price: $1.83 info
Change: -$0.940 (-34%) info
Market Cap: $24.726M info
EDSA
Oct 15, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.62
Real-time Price: $1.83 info
Change: -$0.790 (-30%) info
Market Cap: $24.726M info
EDSA
Oct 15, 2026, 9:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.84
Real-time Price: $1.83 info
Change: -$1.01 (-36%) info
Market Cap: $24.726M info